Sihai network

Shuanghuanglian can inhibit New Coronavirus? What is the function of Shuanghuanglian

Original title: the Chinese Academy of Sciences initially discovered that Shuanghuanglian oral liquid can inhibit New Coronavirus and need a lot of experiments.

Shanghai, China, January 31 (Xia Bin Zheng Yingying), according to the China Academy of Sciences January 31st evening, Shuanghuanglian oral liquid can inhibit New Coronavirus. The joint research of Shanghai Institute of medicine and Wuhan virus of Chinese Academy of Sciences found that Chinese medicine Shuanghuanglian oral liquid can inhibit New Coronavirus (2019-nCoV).

When the reporter of chinanews.com asked for confirmation from the Shanghai Institute of medicine of the Chinese Academy of Sciences that night, relevant personnel said that at present, it is preliminarily found that it has inhibitory effect on (New coronal) virus, but how effective it is for patients, a large number of tests have to be done.

Shuanghuanglian oral liquid is composed of honeysuckle, Scutellaria baicalensis and Forsythia suspensa. Traditional Chinese medicine believes that these three traditional Chinese medicines have good effects of clearing away heat and detoxification and clearing both outside and inside. Modern medical research shows that Shuanghuanglian oral liquid has the effects of broad-spectrum antiviral, bacteriostatic and improving immune function. It is one of the effective broad-spectrum antiviral drugs at present.

Shanghai Institute of pharmacy, Chinese Academy of Sciences has been engaged in antiviral drug research for a long time. Facing the grim situation of New Coronavirus infection, the China Academy of Sciences Shanghai Institute of Materia Medica launched the research team on infectious disease prevention and treatment of pneumonia, led by academician Jiang Hualiang, and focused on the screening and evaluation of new therapeutic candidates for the virus and the new use of old drugs on the basis of previous SARS related research and drug discovery results. Recently, after the joint research of Shanghai Institute of medicine and Wuhan virus, it was found that Chinese medicine Shuanghuanglian oral liquid could inhibit New Coronavirus (2019-nCoV).

It is reported that during SARS in 2003, the Zuo Jianping team of Shanghai Institute of Materia Medica first identified Shuanghuanglian oral liquid as an anti SARS coronavirus. Over the past 10 years, Zuo Jianping's team has continuously studied and successively confirmed that Shuanghuanglian oral liquid has obvious antiviral effect on influenza virus (h7n9, H1N1, H5N1), severe acute respiratory syndrome coronavirus (SARS CoV) and Middle East respiratory syndrome coronavirus (mers). After the outbreak of New Coronavirus 2019-nCoV, the Shanghai Drug Institute combined with the Wuhan virus confirmed that Shuanghuanglian oral liquid had inhibitory effect on the virus.

It is reported that at present, Shuanghuanglian oral liquid has carried out clinical research in Shanghai public health clinical center and Tongji Hospital Affiliated to Huazhong University of science and technology. At the same time, Shanghai Institute of pharmacy has negotiated and reached a cooperation agreement with relevant enterprises to jointly carry out the follow-up research and development of Shuanghuanglian oral liquid and carry out in-depth research on the antiviral efficacy of Shuanghuanglian.

In addition, once the news was released that night, Shuanghuanglian oral liquid sold online in major pharmacies was hot. But there are also some doubts on the Internet. For example, some preliminary evidence suggests that Shuanghuanglian oral liquid may inhibit New Coronavirus, which is being studied. However, there is no convincing clinical trial evidence to prove its efficacy in treating new type of pneumonia. Source: China News Network